Nanotech Indonesia Global Stock Beta

NANO Stock   21.00  1.00  5.00%   
Nanotech Indonesia Global fundamentals help investors to digest information that contributes to Nanotech Indonesia's financial success or failures. It also enables traders to predict the movement of Nanotech Stock. The fundamental analysis module provides a way to measure Nanotech Indonesia's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Nanotech Indonesia stock.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Nanotech Indonesia Global Company Beta Analysis

Nanotech Indonesia's Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.

Beta

 = 

Covariance

Variance

More About Beta | All Equity Analysis
In a nutshell, Beta is a measure of individual stock risk relative to the overall volatility of the stock market. and is calculated based on very sound finance theory - Capital Assets Pricing Model (CAPM).However, since Beta is calculated based on historical price movements it may not predict how a firm's stock is going to perform in the future.
Competition

In accordance with the recently published financial statements, Nanotech Indonesia Global has a Beta of 0.0. This is 100.0% lower than that of the Healthcare sector and 100.0% lower than that of the Medical Devices industry. The beta for all Indonesia stocks is 100.0% lower than that of the firm.

Did you try this?

Run Price Exposure Probability Now

   

Price Exposure Probability

Analyze equity upside and downside potential for a given time horizon across multiple markets
All  Next Launch Module

Nanotech Fundamentals

About Nanotech Indonesia Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Nanotech Indonesia Global's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Nanotech Indonesia using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Nanotech Indonesia Global based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

Other Information on Investing in Nanotech Stock

Nanotech Indonesia financial ratios help investors to determine whether Nanotech Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Nanotech with respect to the benefits of owning Nanotech Indonesia security.